REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886FAD9. A total of 10 filers reported holding REGENERON PHARMACEUTICALS in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,760,000 | -9.0% | 500,000 | 0.0% | 1.20% | +0.3% |
| Q2 2015 | $3,033,000 | +13.0% | 500,000 | 0.0% | 1.20% | +13.9% |
| Q1 2015 | $2,684,000 | +10.0% | 500,000 | 0.0% | 1.05% | +10.2% |
| Q4 2014 | $2,439,000 | +15.9% | 500,000 | 0.0% | 0.95% | +15.2% |
| Q3 2014 | $2,105,000 | +25.2% | 500,000 | 0.0% | 0.83% | +28.2% |
| Q2 2014 | $1,681,000 | -5.9% | 500,000 | 0.0% | 0.65% | -8.8% |
| Q1 2014 | $1,786,000 | +8.8% | 500,000 | 0.0% | 0.71% | +6.5% |
| Q4 2013 | $1,641,000 | -11.9% | 500,000 | 0.0% | 0.66% | -14.5% |
| Q3 2013 | $1,863,000 | +38.8% | 500,000 | 0.0% | 0.78% | +32.1% |
| Q2 2013 | $1,342,000 | – | 500,000 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WELLS FARGO & COMPANY/MN | 10,301,000 | $44,037,000 | 0.02% |
| Allianz Asset Management GmbH | 220,000 | $1,025,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2,000 | $9,000 | 0.00% |